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Abstract
Introduction: A reliable method of intradialysis calcium mass balance quantiﬁcation is far from
been established. We herein investigated the use of a single-pool variable-volume Calcium kinetic
model to assess calcium mass balance in chronic and stable dialysis patients.
Methods: Thirty-four patients on thrice-weekly HD were studied during 240 dialysis sessions. All
patients were dialyzed with a nominal total calcium concentration of 1.50 mmol/L. The main assump-
tion of the model is that the calcium distribution volume is equal to the extracellular volume during
dialysis. This hypothesis is assumed valid if measured and predicted end dialysis plasma water ionized
calcium concentrations are equal. A difference between predicted and measured end-dialysis ionized
Correspondence to: S. Di Filippo, Division of Nephrology, A. Manzoni Hospital, Via dell’Eremo 9/11, 23900 Lecco, Italy. E-
mail: difilippo.salvatore@libero.it
Conflict of Interest: The Authors have nothing to disclose with regards of the present manuscript.
Disclosure of grants or other funding: None
List of abbreviations: 0–t, Initial and final values; Ca21d, Ionized dialysate calcium concentrations (mmol/L); Ca21di, Dialysate
calcium concentration (mmol/L) at the inlet port of dialyzer; Ca21MB, Intra-dialysis ionized calcium mass balance (mmol);
Ca21pw, Ionized plasma water calcium concentrations (mmol/L); Ca21pwi, Plasma water calcium concentration (mmol/L) at
the inlet port of dialyzer; Ca21pwtM, End-dialysis measured plasma water calcium concentration (mmol/L) normalized at pH
7.40; Ca21pwtP, End-dialysis plasma water calcium concentration (mmol/L) predicted by the model; Ca21pwt(P-M), Differ-
ence between end-dialysis plasma water calcium concentration predicted and measured (mmol/L); Ca21uf, Outlet ultrafiltrate
stream calcium concentration (mmol/L) normalized at pH 7.40; CaMB, Intra-dialysis global calcium mass balance (mmol);
D0Ca, Calcium dialysance (L/min) corrected for cardiopulmonary and access recirculation; D0cond, Conductivity dialysance (L/
min) corrected for cardiopulmonar and access recirculation; KoAcond, “Intrinsic” dialysance for conductivity (mL/min);
MCa21, Mobilization of calcium from extracellular fluid compartment (mmol); Na1d, Ionized dialysate sodium concentrations
(mmol/L); Na1pw, Ionized plasma water sodium concentrations (mmol/L); Qbi, Inlet blood flow (mL/min); Qei, Inlet blood
water flow (mL/min); Qdi, Inlet dialysate flow (mL/min); Cdi, Inlet dialysate conductivity (mS/cm); Qf, Total ultrafiltrate (L);
QfECW, Ultrafiltrate removed from the extracellular fluid compartment (L/min); Qpwi, Inlet plasma water flow (L/min); SPVV-
CaKM, Single-compartment variable-volume calcium kinetic model; SPVV-NaKM, Single-compartment variable-volume sodium
kinetic model; Td, Dialysis session duration (min); VCat, End-dialysis calcium distribution volume (L); Vut, End dialysis urea
distribution volume (L); spKt/V, Single Pool Kt/V; a, Donnan factor
VC 2017 International Society for Hemodialysis
DOI:10.1111/hdi.12531
126
Hemodialysis International 2018; 22:126–135
plasma water calcium concentration is a deviation on our main hypothesis, meaning that a substantial
amount of calcium is exchanged between the extracellular volume and a nonmodeled compartment.
Findings: The difference between predicted and measured values was 0.02 mmol/L (range
20.08:0.16 mmol/L). With a mean ionized dialysate calcium concentration of 1.25 mmol/L, calci-
um mass balance was on average negative (mean6 SD 20.8461.33 mmol, range 25.42:2.75).
Predialysis ionized plasma water concentration and total ultraﬁltrate were the most important pre-
dictors of calcium mass balance. A signiﬁcant mobilization of calcium from the extracellular pool
to a nonmodeled pool was calculated in a group of patients.
Discussion: The proposed single pool variable-volume Calcium kinetic model is adequate for pre-
diction and quantiﬁcation of intradialysis calcium mass balance, it can evaluate the eventual calci-
um transfer outside the extracellular pool in clinical practice.
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INTRODUCTION
Management of calcium metabolism in CKD-5D patients
is of paramount importance. Although this is a much-
debated topics, little is known with certainty and most of
the recent guidelines1 are based on experts’ opinions.
Notably the debate on the optimal concentration of calci-
um in the dialysate (d[Ca])2,3 is still open. The optimal
d[Ca] should prevent severe secondary hyperparathyroid-
ism (SHPT), as well as cardiovascular and soft tissue calci-
fications. Some authors support the use of a low d[Ca] to
reduce the long-term risk of vascular and valvular calcifi-
cation4,5 while others suggest avoiding low d[Ca], because
it may favor hypotension, cardiac arrhythmias during
hemodialysis (HD) as well as worsen SHPT.6 Thus, from
the clinical point of view, it is crucial to assess calcium
balance during each HD session to tailor the intradialysis
balance to the patient needs.
Few incongruent studies yielding conflicting results on
intradialytic calcium mass balance (CaMB) have been pub-
lished and little is known on intradialysis CaMB manage-
ment. In the context of the DialysIS study (Dialysis
therapy between Italy and Switzerland, aimed to improve
the personalization of hemodialytic treatments through a
modellistic approach), we evaluated the intradialysis
CaMB by applying a Single-Pool Variable-Volume Calcium
Kinetic Model (SPVV-CaKM) to patients on chronic HD.7
Specifically, we investigated the SPVV-CaKM accuracy in
predicting the serum calcium at the end of dialysis session.
The differences between our proposal and the model sug-
gested by Gotch et al.7 are a different set of parameters
(Donnan’s factor and calcium effective ionic dialysance)
and instead of a theoretic approach, the use of real clinical
data derived by implementing the model in dialysis
patients. The aim of our study is to provide a simple and
precise instrument capable of giving an accurate estimate
of intradialytic calcium mass balance in a clinical setting.
RESULTS
Patients’ data
Thirty-four patients (20 males and 14 females, mean age
71.66 9.7 years, vintage 71.06 55.4 months) on thrice-
weekly HD were studied during 240 sessions (mean
6.56 1.9 for each patient; range 3–9). All patients were
dialysed with a nominal d[Ca] of 1.50 mmol/L; the pre-
scribed blood flow rate (Qbi) ranged between 150 to
350 mL/minutes, dialysate flow rate (Qdi) was fixed to
500 mL/minutes and the treatment time ranged from 3 to
5 hours (Figure 1).
Dialysate Ca21 concentration at the inlet port of dialyzer
(Ca21 di) ranged between 1.16 and 1.35 mmol/L. This
wide range of Ca21 di is a consequence of the individual-
ized dialysate sodium [Na1] prescription (133.86 2.6;
range: 126.6 to 139.6 mmol/L) that is obtained through
changes in dialysate conductivity (range 13.5 to 14.7 mS/
cm; Figure 1). Plasma water ionized calcium concentration
at the start of dialysis (Ca21 pw0) ranged between 1.00
and 1.43 mmol/L, calcium effective ionic dialysance (D0Ca)
between 69.6 and 188.7 mL/minutes and calcium distribu-
tion volume (VCat) between 6.25 and 15.17 l (Figure 1).
Model’s results
The end dialysis calcium concentration in the plasma water
(Ca21 pwtP) was accurately estimated by the single-
compartment variable-volume calcium kinetic model
(SPVV-CaKM) illustrated in7 and modified as described in
Intra-dialysis calcium MB by kinetic model
Hemodialysis International 2018; 22:126–135 127
the methods. Measured (Ca21 pwtM) and predicted (Ca21
pwtP) values and their difference (Ca2 1 pwt(P-M)) are
reported in Table 1. Considering all study participants
(N5 34), Ca21 pwtP and Ca21 pwtM resulted significantly
different (P< 0.001). However, when the measurement
error was taken into account, only an absolute value of
Ca21 pwt(P-M) greater than 0.05 mmol/L was assumed as
evidence of exchange toward a nonmodeled compartment.
Hence, dialysis sessions were divided into two groups:
Group 1 (no calcium flux from the extracellular compart-
ment), absolute Ca21 pwt(P-M) 0.05 mmol/L; Group 2
(calcium flux from the extracellular compartment), absolute
Ca21 pwt(P-M)> 0.05 mmol/L. Group 1 included 192 ses-
sions (80% of all sessions) performed in 29 patients. In this
group, the difference between Ca21 pwtP and Ca21 pwtM
was not statistically significant (Table 1) and no relationship
between Ca21 pwt(P-M) and Ca21 pwtM was noted. Figure
2 depicts the mean value of each patient’s Ca21 pwt(P-M)
plotted against the mean value of Ca21 pwtM in group 1.
The difference from zero was symmetrically distributed and
there was no specific pattern related to Ca21 pwtM.
Conversely, Group 2 included the remaining 48 ses-
sions performed in 8 patients. In this group, Ca21 pwtP
was significantly greater than Ca21 pwtM (Table 1) sug-
gesting calcium exchange with nonmodeled compart-
ments. Global calcium mass balance (Ca21 MB), was on
average negative (20.836 1.33 mmol) due to a larger
convective calcium flux (2.696 1.21 mmol) from the
patient to the dialysate compared to the diffusive calcium
flux (1.866 0.91 mmol) from the dialysate to the patient.
However, a considerable patient-to-patient as well as
intrapatient variability was present. When individual
patients were considered, 26 exhibited a negative Ca21
MB (21.236 0.84 mmol) while 8 patients showed a pos-
itive Ca21 MB (0.706 0.47 mmol; Figure 3).
Compared to patients with negative Ca21 MB, individu-
als with positive Ca21 MB showed a significantly lower lev-
els of serum calcium at dialysis start (Ca21 pw0:
1.126 0.06 vs. 1.196 0.07 mmol/L; P< 0.01) and a sig-
nificantly lower total ultrafiltrate volume (Qf: 1.86 0.9 vs.
2.46 0.7 l; P< 0.05). No significant differences were found
in Ca21 di, D0Ca and Td values, suggesting that a positive
Figure 1 Treatment parameters and input values to SPVV-CaKM (for acronym explanation see List of abbreviations)
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Ca21 MB was supported by a greater diffusive (from dialy-
sate to patient: 2.006 0.86 vs. 1.496 0.70 mmol;
P< 0.001 in Group 2 and 1, respectively) calcium flux,
driven by a greater concentration gradient (Ca21 di–Ca21
pw0: 0.146 0.07 vs. 0.066 0.07 mmol/L; P< 0.001) and
smaller convective (from patient to dialysate) calcium flux.
The opposite was true in case of negative Ca21 MB.
We interpreted the difference between predicted and
measured end-dialysis ionized plasma water calcium con-
centration as an error in the main hypothesis. So, if the
predicted plasma water ionized calcium concentration is
different from the measured value, it means that there is
an exchange of calcium from the extracellular
compartment toward a nonmodeled compartment. We
defined this exchange as sequestration or mobilization
(MCa21, mmol), as in.7
As expected, a significant sequestration of Ca21 from
extracellular fluid compartment (MCa21) was noted in
Group 2 (0.696 0.31 mmol vs. 0.086 0.31 mmol,
P< 0.001, in Group 2 and 1, respectively).
Finally, we verified whether bone remodelling, as esti-
mated by PTH values, could affect Ca21 MB.8 Patients
were divided into two groups according to PTH levels less
than two times the upper values of normality (130 pg/mL) or
more than nine times the upper values of normality (585
pg/mL). Eleven patients showed PTH levels> 585 pg/mL;
Table 1 Mean values of predicted and measured end dialysis plasma water ionized calcium concentration and their
difference
No. of sessions No. of pts
Ca21pwtP
(mmol/L)
Ca21pwtM
(mmol/L)
Ca21pwt
(P-M) (mmol/L) P
240 34 1.336 0.02 1.306 0.05 0.026 0.04 <0.001
192 Group 1 29 1.326 0.04 1.316 0.04 0.016 0.03 NS
48 Group2 8 1.356 0.04 1.286 0.05 0.086 0.03 <0.001
Group 1: patients with Ca21pwt (P-M)< 0.05 mmol/L.
Group 2: patients with Ca21pwt (P-M) 0.05 mmol/L.
Figure 2 Distribution of mean difference between predicted and measured value in patients with Ca21 pwt(P-M)< 0.05 mmol/L.
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6 patients showed PTH levels< 130 pg/mL; 3 patients
exhibited a reduction from high to normal levels during
cinacalcet treatment (Table 2).
DISCUSSION
The optimal d[Ca] choice has important implications in
preventing or at least reducing renal bone disease, cardio-
vascular calcifications and intradialytic arrhythmias and
hypotensions in HD patients. However, how to manipu-
late the intradialysis calcium balance to achieve these
results is still an unanswered question.
Very few incongruent studies on intradialysis
CaMB have been published so far.8–11 The inconsis-
tencies found in these studies can be explained by
the chosen method of CaMB estimation. All of these
studies quantified CaMB collecting the total effluent
dialysate to measure total calcium concentration.
With this procedure, even a low imprecision in the
analytical method to assess [Ca] might induce a sub-
stantial CaMB calculation error. Total calcium is
most frequently measured using spectrophotometry
and the o-cresolphthalein complexone dye. Accord-
ing to a within-run per cent coefficient of variation
of 2.5, the maximum standard deviation with
Table 2 Ca21 MB (mmol) values according to predialysis PTH levels
PTH< 2*65 pg/mL (n5 6) PTH> 9*65 pg/mL (n5 11) P
PTH-0 (pg/mL) 926 34 8116 221 <0.001
PTH-t (pg/mL) 626 35 5546 256* <0.001
Global Ca21MB (mmol) 20.736 1.56 21.266 1.85 NS
Diffusive Ca21MB (mmol) 1.886 0.61 1.566 0.64 NS
Convective Ca21MB (mmol) 2.616 1.38 2.836 1.71 NS
Mca21 (mmol) 0.106 0.27 0.166 0.45 NS
Ca21pw0 (mmol/L) 1.166 0.09 1.186 0.08 NS
Qf (l) 2.26 1 2.76 1 NS
PTH 5 Parathyroid hormone.
*P5 0.02 vs. predialysis values.
Figure 3 Distribution of mass balance in patients with negative and positive global Ca21 MB.
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dialysate [Ca] of 1.25 mmol/L maybe as large as
0.03 mmol/L. Considering a total of 90–120 L of
dialysate per dialysis session, this apparently negligi-
ble imprecision may lead to a substantial error in
the intradialysis CaMB estimation.
It is well known that alkalosis reduces [Ca21] solubili-
ty.12 Hence, ionized calcium based methods11 may over-
estimate CaMB if pH-mediated variation in ionized
calcium concentration are not appropriately accounted.
The inconsistences found in these papers led us to raise
some questions about the proposed methodological
approach and to choose a modellistic solution, based on
the one previously described by Gotch,7 capable of over-
come these difficulties. In this study, intradialysis Ca21
MB was determined by a single-compartment variable-
volume kinetic model enabling calculation of Ca21 con-
tent in the extracellular fluid compartment from the start
to the end of each dialysis session. Prerequisites to use
this method are the accurate estimation of the Donnan
coefficient (a factor) and of the “effective” calcium dialy-
sance. The a factor, we used in our study was obtained
by the ratio between ultrafiltrate and inlet blood stream
ionized calcium concentrations with ultrafiltrate values
normalized at pH 7.40, because ultrafiltrate ionized calci-
um values are also pH dependent.13
We derived the “effective” calcium dialysance from the
conductivity dialysance obtained from the DiascanVR mod-
ule (Baxter Gambro Dasco Spa, Medolla MO). The mean
value of repeated conductivity dialysances using a single-
step conductivity profile, as DiascanVR does, may be
considered an adequate estimate of urea clearance cor-
rected for total recirculation.14 We considered the calcium
dialysance similar to the urea dialysance, given the similar
molecular weight of urea and calcium. These are consid-
ered small molecules (<200 u), thus having similar diffu-
sive proprieties, without considering electric charge. The
dialyzer mass transfer coefficient per area may be consid-
ered similar between the two compounds and the differ-
ence between the two dialysance can be considered
expression of the different effective flows (blood water for
urea and plasma water for calcium).
Most of our patient using a nominal dialysate [Ca] of
1.50 mmol/L showed a neglectable difference between
measured and predicted end-dialysis plasma water ion-
ized calcium concentration suggesting that the model is
accurate, it allows a dialysis calcium mass balance estima-
tion and it may guide individualized d[Ca] prescription.
The fact that Ca21 pwt(P-M) was, in some patients, sig-
nificantly different from zero (P< 0.001) suggests the
existence of a calcium flux from the extracellular compart-
ment to a not modeled pool. In particular, three patients
who experienced dialysis sessions with Ca21 pwt(P-
M) 0.05 mmol/L and later on experienced dialysis ses-
sions with Ca21 pwt(P-M)> 0.05 mmol/L. A post hoc
review of patients’ chart revealed that in all three patients
this phenomenon occurred when treatment with cinacal-
cet was started, suggesting that our method may be able
to catch the effect of treatment on calcium balance during
dialysis. Of course, this intriguing hypothesis needs con-
firmation in a larger specifically designed study.
Figure 4 Clinical applications of SPVV-CaKM. Ionized calcium plasma water concentration is considered low when 0.95
mmol/L and <1.1 mmol/L, normal when 1.1 and <1.25 mmol/L high when 1.25 mmol/L
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The actual distribution volume of calcium during dialysis
is not known, but several authors7,15–17 pointed out that,
when the different compartment involved in calcium metab-
olism are in dynamic-equilibrium, the extracellular volume
could be a fair approximation of the distribution volume of
calcium. The good agreement between the end dialysis Ca21
concentration predicted by the model and the measured val-
ue support this hypothesis under certain conditions.
Since a precise measurement of the rapidly exchange-
able Ca pool and the other compartments that may be
involved in calcium kinetics cannot be made in a simple
and direct manner during the clinical routine, adding to
the SPVV-CaKM compartments that cannot be modeled
can only lead to imprecision and confusion. From this
particular vantage point, a single-pool model represents
an acceptable simplification, with a high degree of accura-
cy and ready-to-use when the underlying hypothesis are
confirmed. In the minority of studied patients, in which
our model predictions were significantly different from
collected data, other compartments may come into play,
but it is still an open question, outside the scope of the
present study, whether and how different factors may
contribute to modify the equilibrium between all the com-
partments possibly involved in calcium homeostasis.
We observed a significant decrease in PTH plasma levels
in all the patients regardless of the Ca mass balance (nega-
tive in 76% patients and positive in the remaining 24%)
supporting the hypothesis that parathyroid glands respond
primarily to the increase in Ca21 pw secondary to the dif-
fusive flux from the dialysate to the patient as it was the
case in our population. We could not find any significant
relationship between PTH levels outside the suggested tar-
get range (2–9 times the upper reference limit for the
assay)1 and global, diffusive, or convective Ca21 MB, pos-
sibly due to the low number of patients with (Table 2). A
decreased diffusive Ca21 MB may account for the negative
to positive Ca21 MB transition observed in patients that
initiated cinacalcet in the course of the study recordings
since this drug modify the calcium/PTH set point and
increases the blood-dialysate calcium gradient. Our results
also suggest that factors such as sodium dialysate profiling
commonly used in daily practice may substantially change
the “nominal” concentration of calcium in dialysate. This
observation may contribute to explain the apparent dis-
crepancy of our results with previous ones since the real
calcium concentration is often lower than the “nominal”
calcium concertation reported in the dialysate bags.
At the present time, there is not a consensus on the
proper management of calcium in CKD-5D patients,
mostly because the pathogenesis and progression of many
mineral-related disorders (e.g., coronary calcifications,
calcific uremic arteriopathy) are not completely under-
stood. The presented kinetic model is a valid instrument
when dealing with this complex and multifaceted prob-
lem and it has several advantage on the calcium mass bal-
ance performed with total or partial dialysate collection,
namely the ease of use in routine clinical practice, the
ability to predict the end dialysis plasma water calcium
concentration when different calcium concentrations in
the dialysate are used and the prediction of calcium that
will not appear in the extracellular volume (MCa21), with
the risk of calcium complexes deposition. In Figure 4, we
propose a practical use of the SPVV-CaKM in clinical rou-
tine, without presumption of completeness. If these
results will be confirmed by other large studies a
nomogram-like approach may also be feasible for a rou-
tine evaluation of Ca21 MB.
This instrument may also provide a common basis for
classifying the patients: as the model takes in considerations
several parameters to estimate calcium balance, classifying
patients based on the estimated balance could avoid impor-
tant confounders and thus improve accuracy and reliability
of calcium homeostasis studies in CKD-5D patients.
The main limitations of this study are the relatively small
sample size and the fact that all study subjects received dial-
ysis with a nominal calcium concentration of 1.50 mmol/L
in the dialysate. The presented model is based on several
hypotheses, many of them are difficult to prove rigorously,
and it needs further validation, including a dedicated study
comparing the model’s performance with different calcium
dialysate concentrations (1.25, 1.50, and 1.75 mmol/L) and
use of drugs that interfere with bone metabolism (e.g., cina-
calcet). However, the rigorous methodology and the wide
range of ionized calcium concentrations in the dialysate uti-
lized are in our opinion the strengths of current findings. In
conclusions, current results suggest that it is feasible to esti-
mate the intradialysis global calcium balance using a single-
compartment variable-volume calcium kinetic model
(SPVV-CaKM). Furthermore, this study shows that using a
fixed nominal dialysate calcium concentration (1.50 mmol/
L), Ca21 MB can vary widely not only between patients but
even in the same patient, according to its pharmacological
treatment. Our data corroborates the notion that global
Ca21 MB depends not only on d[Ca] but also on predialysis
plasma water calcium [Ca2 1 pw0] total ultrafiltration and
bone metabolism. Therefore, it is unlikely that one dialysate
calcium concentrations may be adequate for all the patients.
This is particularly true considering the great variability in
the patient drug prescription for serum PTH, calcium, and
phosphate management. An integrated approach that
encompasses all these factors is needed for a personalized
d[Ca] prescription. In this view, the presented model offer
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to the practising nephrologists an accurate view of what is
going on during dialysis, such as convective removal, diffu-
sive exchanges and quantity of calcium that will not appear
in the extracellular fluid, thus possibly improving the man-
agement of calcium metabolism in CKD-5D patients.
MATERIALS AND METHODS
Experimental design
All patients, after signing the informed consent form,
have been monitored for a minimum of 3 dialysis ses-
sions. During each monitored session, several parameters
has been recorded:
 Dialysis’ duration and total ultrafiltration
 Blood samples for the evaluation of ionized plasma
water calcium and sodium concentrations, pH, urea,
albumin, and PTH concentrations both at the start
and at the end of the treatment. The end-dialysis
sample has been acquired after reduction of blood
flow to 50 mL/minutes for 3 minutes
 Dialysate sample for the determination of ionized
calcium and sodium concentrations, collected from
the prefilter dialysate port thirty minutes after ses-
sion’s start
 Conductivity Dialysance and blood flow values
through the entire session
Calcium modeling
The main hypothesis of the adopted model is that the cal-
cium distribution volume is equal to extracellular volume,
which means that, at least during dialysis treatment, there
is no net exchange between the extracellular volume and
other compartments.
Intradialysis Ca21 MB was defined as the change in
Ca21 content in the extracellular fluid volume during a
dialysis session and calculated according to Equation 2
reported in the Appendix.
All dialysis sessions were performed with Gambro
ArtisTM machine equipped with DiascanVR module for
automatic determination of “effective” conductivity dialy-
sance that is conductivity dialysance corrected for cardio-
pulmonary and access recirculation (D0cond).
14
End-dialysis urea distribution volume (VUt) was deter-
mined using D0cond as input to the 3-point single-pool
variable-volume urea kinetic model.18,19 VUt was used to
estimate end-dialysis calcium distribution volume (VCat)
defined as anatomically equal to the extracellular fluid vol-
ume and about 1/3 of Vut. D
0
cond was also used to calculate
in vivo “intrinsic dialysance” for conductivity (KoAcond)
from which calcium dialysance (D0ca) was derived.
20
A Donnan’s factor (a) of 0.938, obtained from previous-
ly unpublished data on a HDF technique, Hemo-Filtrate
Reinfusion (HFR) able to achieve diffusion and convection
separately through two filters in series,21 was used to
account for the amount of plasma water diffusible Ca2.
Finally, the ultrafiltration rate from extracellular vol-
ume (QfECW) was obtained by the ratio between intradial-
ysis sodium balance, estimated according to single-
compartment variable-volume sodium kinetic model
(SPVV-NaKM)22,23 and the mean value between initial
(Na1 pw0) and final plasma water Na1 concentrations
(Na1 pwt).
Equation 2 accounts for both diffusive and convective
components of calcium flux. Based on the assumptions of
single compartment kinetic models, the convective part is
expressed by the ultrafiltration from the hypothesized dis-
tribution volume, while the diffusion components are
dependent on concentration gradient between dialysate
and plasma, Donnan’s equilibrium and clearance of the
studied molecule.
The difference between end-dialysis ionized plasma
water calcium concentration predicted by the kinetic model
(Ca21 pwtP) and measured value normalized to pH 7.40
(Ca21 pwtM) was considered the most useful variable for
validating the kinetic model. Predicted values were calcu-
lated according to Equation 3, obtained from Equation 2.
Main variables needed for applying Equation 3 were:
 calcium Donnan’s factor (a);
 initial ionized plasma water calcium concentration
(Ca21pw0);
 ionized dialysate calcium concentration (Ca21di);
 initial and final calcium distribution volume
(Vca 0; Vcat);
 calcium dialysance (D;ca);
 ultrafiltration rate from extracellular water (QfECW);
 plasma water flow rate (Qpwi).
Global, diffusive and convective Ca21 MB were calcu-
lated according to Equations 5, 6, and 7 and sequestration
of calcium (MCa21) outside the extracellular fluid com-
partment was calculated according to Equation 4.
All electrolytes’ concentrations and pH values were
obtained using direct ionometry: Stat ProfileVR CCX analy-
ser, Nova Biomedical, Waltham, USA; within-run impre-
cision for Ca21: 2%6 0.05 mmol/L.24 To account for the
changes in pH values which is known to affect Ca21 con-
centrations,13 end of dialysis Ca21 pw and Ca21 uf values
were normalized to the pH value of 7.40 according to
Equation 1 reported in Appendix.
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Statistical analysis
Continuous variables are reported as means6 SD and
compared with Student’s t-test. Variables with a non-
normal distribution are reported as median (range) and
analysed by the Wilcoxon or Mann–Whitney test.
The difference between Ca21 pwtP and Ca21 pwtM val-
ues was considered the most useful variable for validating
the kinetic model. Central tendency and dispersion of this
difference were used to evaluate the accuracy and precision
of the model, respectively. Finally, the adequacy of the
model for the entire spectrum of Ca21 pwtM values was
evaluated by plotting the individual differences of Ca21
pwtP and Ca21 pwtM against Ca21 pwtM (similar to a
Bland-Altman plot). All analysis was performed using R
version 3.2.0; P-values <0.05 were considered significant.
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APPENDIX : EQUATIONS USED TO ASSESS CALCIUM MASS BALANCE
Equation 1: Normalization of end-dialysis measured plasma water ionized calcium concentrations:
Ca21pwtM5 10 log10 Ca
21pwtð Þ2 0:24  7:40 – pHtð Þð Þ
Legend: Ca21pwt and pHt: end-dialysis plasma water ionized calcium concentrations and pH as determined by direct
ionometry.
Equation 2: Change in Ca21 content in the extracellular fluid volume
d Ca21pw  VCa =dt5D’Ca  Ca21di2 a  Ca21pwi 2QfECW  Ca21pwi1D’Ca=Qpwi  Ca21di2 a  Ca21pwi 
Legend: VCa, Ca distribution volume (l); D’ca, “effective” Ca dialysance (L/min); Ca
21di, inlet dialysate ionized Ca
concentration (mmol/L); a, Donnan’s factor; Ca21pwi, inlet plasma water ionized Ca concentration (mmol/L); QfECW,
ultrafiltrate removed from extracellular volume (L/min).
Equation 3: End-dialysis ionized plasma water calcium concentration predicted by the kinetic model (Ca21pwtP)
Ca21pwtP5
1
a
 Ca21di2 Ca21di2 a  Ca21pw0   VCat
VCa0
  D’Caa  1QfECW2 1Qpwi
  0
B@
1
CA
Legend: 0 and t stand for initial and final values; Qpwi, plasma inlet water flow rate (l/min)
Equation 4-7: Global (gCa21MB), diffusive (dCa21MB) convective (cCa21MB) calcium mass balances and Ca21
sequestration (MCa21) outside the extracellular fluid.
MCa21 mmolð Þ5VCat  Ca21pwtP –Ca21pwtM
 
(4)
gCa21MB mmolð Þ5 VCat  Ca21pwtM2VCa0  Ca21pw0
 
1MCa21 (5)
dCa21MB mmolð Þ5VCa0  Ca21pwtM2Ca21pw0
 
1MCa21 (6)
cCa21MB mmolð Þ5 gCa21MB2 dCa21MB (7)
Legend: plasma water calcium concentration predicted by the kinetic model (Ca21pwtP) and measured value
normalized to pH 7.40 (Ca21pwtM); calcium sequestration (MCa21); global (gCa21MB), diffusive (dCa21MB)
convective (cCa21MB) calcium mass balances and; VCa calcium distribution volume.
Intra-dialysis calcium MB by kinetic model
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